COVID-19 mRNA vaccine approvals: key lessons for cell & gene therapy and mRNA therapeutic development

Cell & Gene Therapy Insights 2021; 7(6), 761–771

10.18609/cgti.2021.092

Published: 26 July 2021
Innovator Insight
Joseph Barberio, Christoph Kröner, Venkata Indurthi, Scott Zobbi

Joseph Barberio

Director, mRNA Process Development, Strand Therapeutics

Christoph Kröner

Director DNA Process Development & Cap Technology, BioNTech SE

Venkata Indurthi

Vice President Research and Development, Aldevron

Scott Zobbi

Senior Manager Business Development for Custom POROS Resins, Bioproduction Division, Thermo Fisher Scientific